-transparent.png){kind=logo}
The effect of hydrochlorothiazide on the formation of renal stones was evaluated by quantitative assessment of the propensity of urine to undergo crystallization of calcium oxalate. In seven patients with calcium urolithiasis (three with absorptive hypercalciuria, one with renal hypercalciuria, and three with normocalciuric nephrolithiasis), the urinary activity product ratio and formation product ratio of calcium oxalate were measured both on and off therapy with hydrochlorothiazide (50 mg orally twice a day). The activity product ratio (state of saturation with respect to calcium oxalate) decreased in the majority of cases, primarily as a result of the fall in urinary calcium. The formation product ratio (limit of metastability) increased in all cases; the cause of the increase was not readily apparent. Both changes reduced the propensity of urine to undergo crystallization of calcium oxalate, and therefore may account for the clinical improvement reported during thiazide therapy in nephrolithiasis.
A Woelfel, and
R A Kaplan, and
C Y Pak
January 1984,
Nephrologie,
A Woelfel, and
R A Kaplan, and
C Y Pak
November 1975,
Metabolism: clinical and experimental,
A Woelfel, and
R A Kaplan, and
C Y Pak
January 1986,
European urology,
A Woelfel, and
R A Kaplan, and
C Y Pak
January 1987,
Urological research,
A Woelfel, and
R A Kaplan, and
C Y Pak
May 1978,
Investigative urology,
A Woelfel, and
R A Kaplan, and
C Y Pak
March 1994,
Scanning microscopy,
A Woelfel, and
R A Kaplan, and
C Y Pak
January 1992,
Urological research,
A Woelfel, and
R A Kaplan, and
C Y Pak
December 1980,
Biochemical and biophysical research communications,
A Woelfel, and
R A Kaplan, and
C Y Pak
January 1983,
The Journal of urology,
A Woelfel, and
R A Kaplan, and
C Y Pak
January 1998,
Hinyokika kiyo. Acta urologica Japonica,
